XML 21 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Long-Term Debt and Notes Payable
9 Months Ended
Sep. 30, 2018
Debt Disclosure [Abstract]  
Long-Term Debt and Notes Payable Long-Term Debt and Notes Payable
For purposes of this indebtedness footnote, references to Select exclude Concentra because the Concentra credit facilities are non-recourse to Holdings and Select.
As of September 30, 2018, the Company’s long-term debt and notes payable are as follows (in thousands):
 
Principal
Outstanding
 
Unamortized
Premium
(Discount)
 
Unamortized
Issuance
Costs
 
Carrying
Value
 
 
Fair
Value
Select:
 

 
 

 
 

 
 

 
 
 

6.375% senior notes
$
710,000

 
$
607

 
$
(5,122
)
 
$
705,485

 
 
$
718,875

Credit facilities:
 

 
 

 
 

 
 

 
 
 

Revolving facility
65,000

 

 

 
65,000

 
 
59,800

Term loans
1,132,750

 
(11,000
)
 
(11,058
)
 
1,110,692

 
 
1,139,830

Other
49,004

 

 
(508
)
 
48,496

 
 
48,496

Total Select debt
1,956,754

 
(10,393
)
 
(16,688
)
 
1,929,673

 
 
1,967,001

Concentra:
 

 
 

 
 

 
 

 
 
 

Credit facilities:
 

 
 

 
 

 
 

 
 
 

Term loans
1,414,175

 
(3,078
)
 
(20,417
)
 
1,390,680

 
 
1,427,181

Other
9,355

 

 

 
9,355

 
 
9,355

Total Concentra debt
1,423,530

 
(3,078
)
 
(20,417
)
 
1,400,035

 
 
1,436,536

Total debt
$
3,380,284

 
$
(13,471
)
 
$
(37,105
)
 
$
3,329,708

 
 
$
3,403,537


 
Principal maturities of the Company’s long-term debt and notes payable are approximately as follows (in thousands):
 
2018
 
2019
 
2020
 
2021
 
2022
 
Thereafter
 
Total
Select:
 

 
 

 
 

 
 

 
 

 
 

 
 

6.375% senior notes
$

 
$

 
$

 
$
710,000

 
$

 
$

 
$
710,000

Credit facilities:
 

 
 

 
 

 
 

 
 

 
 

 
 

Revolving facility

 

 

 

 
65,000

 

 
65,000

Term loans
2,875

 
11,500

 
11,500

 
11,500

 
11,500

 
1,083,875

 
1,132,750

Other
3,992

 
5,391

 
24,285

 
221

 

 
15,115

 
49,004

Total Select debt
6,867

 
16,891

 
35,785

 
721,721

 
76,500

 
1,098,990

 
1,956,754

Concentra:
 

 
 

 
 

 
 

 
 

 
 

 
 

Credit facilities:
 

 
 

 
 

 
 

 
 

 
 

 
 

Term loans

 

 
5,719

 
12,365

 
1,156,091

 
240,000

 
1,414,175

Other
1,341

 
3,625

 
346

 
346

 
324

 
3,373

 
9,355

Total Concentra debt
1,341

 
3,625

 
6,065

 
12,711

 
1,156,415

 
243,373

 
1,423,530

Total debt
$
8,208

 
$
20,516

 
$
41,850

 
$
734,432

 
$
1,232,915

 
$
1,342,363

 
$
3,380,284



As of December 31, 2017, the Company’s long-term debt and notes payable are as follows (in thousands):
 
Principal
Outstanding
 
Unamortized
Premium
(Discount)
 
Unamortized
Issuance
Costs
 
Carrying
Value
 
 
Fair
Value
Select:
 

 
 

 
 

 
 

 
 
 

6.375% senior notes
$
710,000

 
$
778

 
$
(6,553
)
 
$
704,225

 
 
$
727,750

Credit facilities:
 

 
 

 
 

 
 

 
 
 

Revolving facility
230,000

 

 

 
230,000

 
 
211,600

Term loans
1,141,375

 
(12,445
)
 
(12,500
)
 
1,116,430

 
 
1,154,215

Other
36,877

 

 
(533
)
 
36,344

 
 
36,344

Total Select debt
2,118,252

 
(11,667
)
 
(19,586
)
 
2,086,999

 
 
2,129,909

Concentra:
 

 
 

 
 

 
 

 
 
 

Credit facilities:
 

 
 

 
 

 
 

 
 
 

Term loans
619,175

 
(2,257
)
 
(10,668
)
 
606,250

 
 
625,173

Other
6,653

 

 

 
6,653

 
 
6,653

Total Concentra debt
625,828

 
(2,257
)
 
(10,668
)
 
612,903

 
 
631,826

Total debt
$
2,744,080

 
$
(13,924
)
 
$
(30,254
)
 
$
2,699,902

 
 
$
2,761,735


 Select Credit Facilities
On March 22, 2018, Select entered into Amendment No. 1 to the senior secured credit agreement (the “Select credit agreement”) dated March 6, 2017. The Select credit agreement originally provided for $1.6 billion in senior secured credit facilities comprised of $1.15 billion in term loans (the “Select term loans”) and a $450.0 million revolving credit facility (the “Select revolving facility” and together with the Select term loans, the “Select credit facilities”), including a $75.0 million sublimit for the issuance of standby letters of credit.
Amendment No. 1 (i) decreased the applicable interest rate on the Select term loans from the Adjusted LIBO Rate (as defined in the Select credit agreement and subject to an Adjusted LIBO floor of 1.00%) plus 3.50% to the Adjusted LIBO Rate plus a percentage ranging from 2.50% to 2.75%, or from the Alternative Base Rate (as defined in the Select credit agreement and subject to an Alternate Base Rate floor of 2.00%) plus 2.50% to the Alternative Base Rate plus a percentage ranging from 1.50% to 1.75%, in each case based on Select’s total net leverage ratio (as defined in the Select credit agreement); (ii) decreased the applicable interest rate on the loans outstanding under the Select revolving credit facility from the Adjusted LIBO Rate plus a percentage ranging from 3.00% to 3.25% to the Adjusted LIBO Rate plus a percentage ranging from 2.50% to 2.75%, or from the Alternative Base Rate plus a percentage ranging from 2.00% to 2.25% to the Alternative Base Rate plus a percentage ranging from 1.50% to 1.75%, in each case based on Select’s total net leverage ratio; (iii) extended the maturity date for the Select term loans from March 6, 2024 to March 6, 2025; and (iv) made certain other technical amendments to the Select credit agreement as set forth therein.
Concentra Credit Facilities
Concentra First Lien Credit Agreement
On February 1, 2018, Concentra entered into an amendment to its first lien credit agreement (the “Concentra first lien credit agreement”) dated June 1, 2015, by and among Concentra, as the borrower, Concentra Holdings, Inc., a subsidiary of Concentra Group Holdings Parent, JPMorgan Chase Bank, N.A., as the administrative agent and the collateral agent, and the other lenders party thereto. Concentra used borrowings under the Concentra first lien credit agreement and the Concentra second lien credit agreement, as described below, together with cash on hand, to pay the cash purchase price for all of the issued and outstanding stock of U.S. HealthWorks to DHHC and to finance the redemption and reorganization transactions executed under the Purchase Agreement (as described in Note 3), as well as to pay fees and expenses associated with the financing.
Concentra amended the Concentra first lien credit agreement to, among other things, provide for (i) an additional $555.0 million in tranche B term loans that, along with the existing tranche B term loans under the Concentra first lien credit agreement, have a maturity date of June 1, 2022 (collectively, the “Concentra first lien term loan”) and (ii) an additional $25.0 million to the $50.0 million, five-year revolving credit facility under the terms of the existing Concentra first lien credit agreement. The tranche B term loans bear interest at a rate equal to the Adjusted LIBO Rate (as defined in the Concentra first lien credit agreement) plus 2.75% (subject to an Adjusted LIBO Rate floor of 1.00%) for Eurodollar Borrowings (as defined in the Concentra first lien credit agreement), or Alternate Base Rate (as defined in the Concentra first lien credit agreement) plus 1.75% (subject to an Alternate Base Rate floor of 2.00%) for ABR Borrowings (as defined in the Concentra first lien credit agreement). All other material terms and conditions applicable to the original tranche B term loan commitments are applicable to the additional tranche B term loans created under the Concentra first lien credit agreement.
Concentra Second Lien Credit Agreement
On February 1, 2018, Concentra entered into a second lien credit agreement (the “Concentra second lien credit agreement” and, together with the Concentra first lien credit agreement, the “Concentra credit facilities”) with Concentra Holdings, Inc., Wells Fargo Bank, National Association, as the administrative agent and the collateral agent, and the other lenders party thereto.
The Concentra second lien credit agreement provided for $240.0 million in term loans (the “Concentra second lien term loan” and, together with the Concentra first lien term loan, the “Concentra term loans”) with a maturity date of June 1, 2023. Borrowings under the Concentra second lien credit agreement bear interest at a rate equal to the Adjusted LIBO Rate (as defined in the Concentra second lien credit agreement) plus 6.50% (subject to an Adjusted LIBO Rate floor of 1.00%), or Alternate Base Rate (as defined in the Concentra second lien credit agreement) plus 5.50% (subject to an Alternate Base Rate floor of 2.00%).
In the event that, on or prior to February 1, 2019, Concentra prepays any of the Concentra second lien term loan to refinance such term loans, Concentra shall pay a premium of 2.00% of the aggregate principal amount of the Concentra second lien term loan prepaid. If Concentra prepays any of the Concentra second lien term loan to refinance such term loans on or prior to February 1, 2020, Concentra shall pay a premium of 1.00% of the aggregate principal amount of the Concentra second lien term loan prepaid.
Concentra will be required to prepay borrowings under the Concentra second lien term loan with (i) 100% of the net cash proceeds received from non-ordinary course asset sales or other dispositions, or as a result of a casualty or condemnation, subject to reinvestment provisions and other customary carveouts and the payment of certain indebtedness secured by liens, (ii) 100% of the net cash proceeds received from the issuance of debt obligations other than certain permitted debt obligations, and (iii) 50% of excess cash flow (as defined in the Concentra second lien credit agreement) if Concentra’s leverage ratio is greater than 4.25 to 1.00 and 25% of excess cash flow if Concentra’s leverage ratio is less than or equal to 4.25 to 1.00 and greater than 3.75 to 1.00, in each case, reduced by the aggregate amount of term loans and certain debt optionally prepaid during the applicable fiscal year and the aggregate amount of senior revolving commitments reduced permanently during the applicable fiscal year (other than in connection with a refinancing). Concentra will not be required to prepay borrowings with excess cash flow if Concentra’s leverage ratio is less than or equal to 3.75 to 1.00.
The Concentra second lien credit agreement also contains a number of affirmative and restrictive covenants, including limitations on mergers, consolidations and dissolutions; sales of assets; investments and acquisitions; indebtedness; liens; affiliate transactions; and dividends and restricted payments. The Concentra second lien credit agreement contains events of default for non-payment of principal and interest when due (subject to a grace period for interest), cross-default and cross-acceleration provisions and an event of default that would be triggered by a change of control.
The borrowings under the Concentra second lien term loan are guaranteed, on a second lien basis, by Concentra Holdings, Inc., Concentra, and certain domestic subsidiaries of Concentra and will be guaranteed by Concentra’s future domestic subsidiaries (other than Excluded Subsidiaries and Consolidated Practices, each as defined in the Concentra second lien credit agreement). The borrowings under the Concentra second lien term loan are secured by substantially all of Concentra’s and its domestic subsidiaries’ existing and future property and assets and by a pledge of Concentra’s capital stock, the capital stock of certain of Concentra’s domestic subsidiaries and up to 65% of the voting capital stock and 100% of the non-voting capital stock of Concentra’s foreign subsidiaries, if any.
Loss on Early Retirement of Debt
The amendments to the Select credit facilities and Concentra credit facilities resulted in losses on early retirement of debt totaling $10.3 million for the nine months ended September 30, 2018. The losses on early retirement of debt consisted of $0.5 million of debt extinguishment losses and $9.8 million of debt modification losses during the nine months ended September 30, 2018.
Fair Value
The Company considers the inputs in the valuation process to be Level 2 in the fair value hierarchy for Select’s 6.375% senior notes and for its credit facilities. Level 2 in the fair value hierarchy is defined as inputs that are observable for the asset or liability, either directly or indirectly, which includes quoted prices for identical assets or liabilities in markets that are not active.
The fair values of the Select credit facilities and the Concentra credit facilities were based on quoted market prices for this debt in the syndicated loan market. The fair value of Select’s 6.375% senior notes was based on quoted market prices. The carrying amount of other debt, principally short-term notes payable, approximates fair value.